Deciphera Pharmaceuticals, Inc. Increase (Decrease) in Accounts Receivable
Deciphera Pharmaceuticals, Inc. reported Increase (Decrease) in Accounts Receivable of $878.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2024-03-31 was $878.00K.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-12-31 was $4.17M.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-09-30 was $4.49M.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-06-30 was $766.00K, a 72.99% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $9.35M, a 423.82% increase from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $1.78M, a 73.37% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2021 was $6.70M, a 51.79% decline from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2020 was $13.90M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2024-03-31 | $878.00K 10-Q · filed 2024-05-10 | $5.04M derived: sum of 2 quarters · filed 2024-05-10 | $9.53M derived: sum of 3 quarters · filed 2024-05-10 | $10.30M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $8.66M derived: sum of 2 quarters · filed 2024-02-07 | $9.42M derived: sum of 3 quarters · filed 2024-02-07 | $9.35M 10-K · filed 2024-02-07 |
| 2023-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $5.25M derived: sum of 2 quarters · filed 2023-10-30 | $5.18M 10-Q · filed 2023-10-30 | $3.95M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $689.00K 10-Q · filed 2023-08-09 | -$541.00K derived: sum of 3 quarters · filed 2024-05-10 | -$2.92M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | -$77.00K 10-Q · filed 2024-05-10 | -$1.31M derived: sum of 2 quarters · filed 2024-05-10 | -$3.69M derived: sum of 3 quarters · filed 2024-05-10 | -$854.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | -$3.61M derived: sum of 2 quarters · filed 2024-02-07 | -$777.00K derived: sum of 3 quarters · filed 2024-02-07 | $1.78M 10-K · filed 2024-02-07 |
| 2022-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $453.00K derived: sum of 2 quarters · filed 2023-10-30 | $3.01M 10-Q · filed 2023-10-30 | $5.56M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $2.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $5.40M 10-Q · filed 2023-08-09 | $7.94M derived: sum of 3 quarters · filed 2024-02-07 | $7.38M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $2.56M 10-Q · filed 2023-05-03 | $5.11M derived: sum of 2 quarters · filed 2024-02-07 | $4.55M derived: sum of 3 quarters · filed 2024-02-07 | $1.33M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $1.99M derived: sum of 2 quarters · filed 2024-02-07 | -$1.23M derived: sum of 3 quarters · filed 2024-02-07 | $6.70M 10-K · filed 2024-02-07 |
| 2021-09-30 | -$559.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$3.77M derived: sum of 2 quarters · filed 2022-11-03 | $4.15M 10-Q · filed 2022-11-03 | $6.24M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $4.71M 10-Q · filed 2022-08-04 | $6.79M derived: sum of 3 quarters · filed 2023-02-07 | $11.22M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $7.92M 10-Q · filed 2022-05-04 | $10.01M derived: sum of 2 quarters · filed 2023-02-07 | $14.44M derived: sum of 3 quarters · filed 2023-02-07 | $21.82M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $6.51M derived: sum of 2 quarters · filed 2023-02-07 | $13.90M derived: sum of 3 quarters · filed 2023-02-07 | $13.90M 10-K · filed 2023-02-07 |
| 2020-09-30 | $4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $11.81M derived: sum of 2 quarters · filed 2021-11-02 | $11.81M 10-Q · filed 2021-11-02 | $11.81M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $7.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $7.38M 10-Q · filed 2021-08-03 | $7.38M derived: sum of 3 quarters · filed 2022-02-08 | -$12.62M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-02-08 | -$20.00M derived: sum of 3 quarters · filed 2022-02-08 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | -$20.00M derived: sum of 2 quarters · filed 2022-02-08 | $0.00 10-K · filed 2022-02-08 | |
| 2019-09-30 | -$20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $20.00M 10-Q · filed 2020-08-04 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-09 |